Optimal Care Pathways for lymphoma patients
- Hodgkin lymphoma
- Non-Hodgkin lymphoma
Just 28 days after Graeme Ardern had CAR T-cell therapy, he received the most amazing news - he’d had a complete metabolic response.Â
Megan Reid was about to begin her last two years of high school when she was diagnosed with a blood cancer.
It was 2014, and Tom and his girlfriend had just discovered they were expecting their first child. Just weeks later, Tom found himself experiencing some concerning symptoms. After much investigation, he was diagnosed with Hodgkin lymphoma. Tom's interview sheds light on what it was like to be diagnosed with a blood cancer as a young adult. He shares his experience of diagnosis, and autologous transplant, all while bringing a new baby into the world.
Newly revised optimal care pathways (OCPs) provide best practice information for the treatment and care of people living with acute myeloid leukaemia (AML), and diffuse large B-cell lymphoma (DLBCL) and Hodgkin lymphoma (HL).Â
Dr Piers Blombery explains the basics of molecular testing which informs the treatment of blood cancer. Â
After a misdiagnosis and delayed biopsy, Steph Eliot was finally diagnosed with Stage 2 Hodgkin lymphoma (HL).
Julian Lindsay’s goal is to set up an international study aimed at improving survival and quality of life through drug optimisation.